Epstein-Barr virus-specific cytotoxic T lymphocyte precursors (EBV-CTLp) after tabelecleucel correlates with response & survival in rituximab relapsing or refractory EBV posttransplant lymphoproliferative disease (PTLD) Meeting Abstract

  

Authors:	Prockop, S.; Shen, R. R.; Guzman-Becerra, N.; Sun, Y.; Forozan, F.; Doubrovina, E.; O'Reilly, R. J.; Li, X.; Hiremath, M.; Gamelin, L.; Navarro, W.; Aftab, B. T.
Abstract Title:	Epstein-Barr virus-specific cytotoxic T lymphocyte precursors (EBV-CTLp) after tabelecleucel correlates with response & survival in rituximab relapsing or refractory EBV posttransplant lymphoproliferative disease (PTLD)
Meeting Title:	ISCT 2020 Paris Virtual
Journal Title:	Cytotherapy
Volume:	22
Issue:	5 Suppl.
Meeting Dates:	2020 May 28-29
Meeting Location:	Virtual
ISSN:	1465-3249
Publisher:	Elsevier Science Ltd.
Date Published:	2020-05-01
Start Page:	S135
Language:	English
ACCESSION:	WOS:000536174900299
PROVIDER:	wos
DOI:	10.1016/j.jcyt.2020.03.265
Notes:	Meeting Abstract: 262 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/168019